{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T11:08:14Z","timestamp":1781348894136,"version":"3.54.1"},"reference-count":33,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T00:00:00Z","timestamp":1764460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Inflammatory bowel diseases (IBDs) comprise a group of idiopathic, chronic, relapsing, and inflammatory conditions, which include ulcerative colitis (UC) and Crohn\u2019s disease (CD) [...]<\/jats:p>","DOI":"10.3390\/ijms262311611","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T08:13:49Z","timestamp":1764576829000},"page":"11611","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Special Issue \u201cDrugs in Inflammatory Bowel Diseases\u201d"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3303-0674","authenticated-orcid":false,"given":"Vanessa","family":"D\u2019Antongiovanni","sequence":"first","affiliation":[{"name":"Unit of Human Histology and Embryology, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzia","family":"Bernardini","sequence":"additional","affiliation":[{"name":"Unit of Human Histology and Embryology, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2644-5430","authenticated-orcid":false,"given":"Carolina","family":"Pellegrini","sequence":"additional","affiliation":[{"name":"Unit of Human Histology and Embryology, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,30]]},"reference":[{"key":"ref_1","first-page":"e41120","article-title":"Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation","volume":"15","author":"Muzammil","year":"2023","journal-title":"Cureus"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/apt.17370","article-title":"Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease","volume":"57","author":"Jayasooriya","year":"2023","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"izaf225","DOI":"10.1093\/ibd\/izaf225","article-title":"Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Pathophysiology to Precision Therapeutics","volume":"4","author":"Selvakumar","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Calvez, V., Puca, P., Di Vincenzo, F., Del Gaudio, A., Bartocci, B., Murgiano, M., Iaccarino, J., Parand, E., Napolitano, D., and Pugliese, D. (2025). Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases. Biomedicines, 13.","DOI":"10.3390\/biomedicines13020305"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","article-title":"Macrophages in intestinal homeostasis and inflammatory bowel disease","volume":"20","author":"Hegarty","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2468-1253(24)00390-X","article-title":"The intestinal barrier: A pivotal role in health, inflammation, and cancer","volume":"10","author":"Neurath","year":"2025","journal-title":"lancet. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Zhu, M., Song, Y., Xu, Y., and Xu, H. (2023). Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241311004"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Huang, Y., Wu, M., Xiao, H., Liu, H., and Yang, G. (2022). Mesalamine-Mediated Amelioration of Experimental Colitis in Piglets Involves Gut Microbiota Modulation and Intestinal Immune Cell Infiltration. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.883682"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Dahl, J.-U., Gray, M.J., Bazopoulou, D., Beaufay, F., Lempart, J., Koenigsknecht, M.J., Wang, Y., Baker, J.R., Hasler, W.L., and Young, V.B. (2017). The anti-inflammatory drug mesalamine targets bacterial polyphosphate accumulation. Nat. Microbiol., 2.","DOI":"10.1038\/nmicrobiol.2016.267"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Imbrizi, M., Magro, F., and Coy, C.S.R. (2023). Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years. Pharmaceuticals, 16.","DOI":"10.3390\/ph16091272"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7812\/TPP\/21.073","article-title":"Relapse-Free Course in Nearly Half of Crohn\u2019s Disease Patients with Infliximab and Plant-Based Diet as First-Line Therapy: A Single-Group Trial","volume":"26","author":"Chiba","year":"2022","journal-title":"Perm. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/1744666X.2023.2292768","article-title":"Management and treatment optimization of patients with mild to moderate ulcerative colitis","volume":"20","author":"Fasulo","year":"2024","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_13","first-page":"923","article-title":"Common Instances of Low-value Care in Inflammatory Bowel Diseases","volume":"22","author":"Singh","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"pbad031","DOI":"10.1093\/pcmedi\/pbad031","article-title":"The significance of long non-coding RNAs in the pathogenesis, diagnosis and treatment of inflammatory bowel disease","volume":"6","author":"Jiang","year":"2023","journal-title":"Precis. Clin. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e32606","DOI":"10.1016\/j.heliyon.2024.e32606","article-title":"The role of long non-coding RNA in Crohn\u2019s disease","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Baldan-Martin, M., Rub\u00edn de C\u00e9lix, C., Orejudo, M., Ortega Moreno, L., Fern\u00e1ndez-Tom\u00e9, S., Soleto, I., Ramirez, C., Arroyo, R., Fern\u00e1ndez, P., and Santander, C. (2023). Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn\u2019s Disease Patients and Effect of Anti-TNF-\u03b1 Treatment on Their Modulation. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242115691"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Subudhi, R.N., Poonia, N., Singh, D., and Arora, V. (2024). Natural approaches for the management of ulcerative colitis: Evidence of preclinical and clinical investigations. Nat. Products Bioprospect., 14.","DOI":"10.1007\/s13659-024-00463-x"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e70067","DOI":"10.1002\/mnfr.70067","article-title":"Evidence for a Modulatory Effect of a 12-Week Pomegranate Juice Intervention on the Transcriptional Response in Inflammatory Bowel Disease Patients Reducing Fecal Calprotectin Levels: Findings From a Proof-of-Principle Study","volume":"69","author":"Minato","year":"2025","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Li, H., Ruan, J., Huang, J., Yang, D., Yu, H., Wu, Y., Zhang, Y., and Wang, T. (2023). Pomegranate (Punica granatum L.) and Its Rich Ellagitannins as Potential Inhibitors in Ulcerative Colitis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242417538"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"otab034","DOI":"10.1093\/crocol\/otab034","article-title":"Chronic Abdominal Pain in IBD Research Initiative: Unraveling Biological Mechanisms and Patient Heterogeneity to Personalize Treatment and Improve Clinical Outcomes","volume":"3","author":"Honig","year":"2021","journal-title":"Crohn\u2019s Colitis 360"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"otab073","DOI":"10.1093\/crocol\/otab073","article-title":"Post-inflammatory Abdominal Pain in Patients with Inflammatory Bowel Disease During Remission: A Comprehensive Review","volume":"3","author":"Takahashi","year":"2021","journal-title":"Crohn\u2019s Colitis 360"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"otad055","DOI":"10.1093\/crocol\/otad055","article-title":"Abdominal Pain in Inflammatory Bowel Disease: An Evidence-Based, Multidisciplinary Review","volume":"5","author":"Coates","year":"2023","journal-title":"Crohn\u2019s Colitis 360"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s11064-017-2288-7","article-title":"L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain","volume":"42","author":"Ferreira","year":"2017","journal-title":"Neurochem. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00023210-200721001-00005","article-title":"Acetyl-L-carnitine in neuropathic pain: Experimental data","volume":"21","author":"Chiechio","year":"2007","journal-title":"CNS Drugs"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Lucarini, E., Micheli, L., Toti, A., Ciampi, C., Margiotta, F., Di Cesare Mannelli, L., and Ghelardini, C. (2023). Anti-Hyperalgesic Efficacy of Acetyl L-Carnitine (ALCAR) Against Visceral Pain Induced by Colitis: Involvement of Glia in the Enteric and Central Nervous System. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914841"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann. Afr. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100347","DOI":"10.1016\/j.metop.2025.100347","article-title":"Unveiling the link between chronic inflammation and cancer","volume":"25","author":"Tripathi","year":"2025","journal-title":"Metab. open"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10151-019-1926-2","article-title":"Colorectal cancer in inflammatory bowel disease: Review of the evidence","volume":"23","author":"Keller","year":"2019","journal-title":"Tech. Coloproctol."},{"key":"ref_29","first-page":"450","article-title":"Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study","volume":"26","author":"Biancone","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ibd\/izac096","article-title":"Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank","volume":"29","author":"Wu","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Oh, J.M., Kim, S., Tsung, C., Kent, E., Jain, A., Ruff, S.M., and Zhang, H. (2025). Comprehensive review of the resistance mechanisms of colorectal cancer classified by therapy type. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1571731"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Abdelaziz, R.F., Hussein, A.M., Kotob, M.H., Weiss, C., Chelminski, K., Stojanovic, T., Studenik, C.R., and Aufy, M. (2023). Enhancement of Radiation Sensitivity by Cathepsin L Suppression in Colon Carcinoma Cells. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242317106"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11611\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T08:33:46Z","timestamp":1764578026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,30]]},"references-count":33,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262311611"],"URL":"https:\/\/doi.org\/10.3390\/ijms262311611","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,30]]}}}